Literature DB >> 16343827

TNFRSF11B gene variants and bone mineral density in postmenopausal women in Malta.

C Vidal1, M Brincat, A Xuereb Anastasi.   

Abstract

UNLABELLED: A number of polymorphisms in various genes have been identified and associated with bone mineral density (BMD) and with an increased risk of osteoporosis.
OBJECTIVE: In this study, three single nucleotide polymorphisms (SNPs) within the TNFRSF11B gene were studied for association with an increased risk of osteoporosis in postmenopausal Maltese women (n=126).
METHODOLOGY: Analysis was performed by PCR restriction fragment length polymorphism (RFLP) while BMD at the lumbar spine, femoral neck, Ward's triangle and trochanter was measured by DEXA.
RESULTS: No significant association was observed between genotypes and BMD for all polymorphisms studied within this gene. Homozygotes CC (T(950)-C) were observed to have the highest BMD at all anatomical sites although statistical significance was not reached when comparing the three genotypes. A statistical significant difference was observed in the distribution of genotype frequencies for this polymorphism between normal individuals and those that were either osteopenic or osteoporotic at one or both anatomical sites, with the TT genotype associated more frequently with low BMD. The T(950)-C and G(1181)-C polymorphisms were in strong linkage disequilibrium with each other but not with the A(163)-G polymorphism further upstream in the OPG promoter. Statistical significance was reached when constructing haplotypes, where the A-T-G haplotype was found to be more frequent in individuals with low BMD.
CONCLUSIONS: These results indicate the possible role of TNFRSF11B gene variants in postmenopausal bone loss in women in Malta.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16343827     DOI: 10.1016/j.maturitas.2005.11.003

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  16 in total

Review 1.  Quantitative trait loci, genes, and polymorphisms that regulate bone mineral density in mouse.

Authors:  Qing Xiong; Yan Jiao; Karen A Hasty; S Terry Canale; John M Stuart; Wesley G Beamer; Hong-Wen Deng; David Baylink; Weikuan Gu
Journal:  Genomics       Date:  2009-01-14       Impact factor: 5.736

2.  Polymorphism in vitamin D receptor and osteoprotegerin genes in Egyptian rheumatoid arthritis patients with and without osteoporosis.

Authors:  Yousry Mostafa Hussien; Amal Shehata; Rehab A Karam; Saad S Alzahrani; Hanem Magdy; Abeer M El-Shafey
Journal:  Mol Biol Rep       Date:  2012-12-28       Impact factor: 2.316

3.  TNFRSF11B gene polymorphisms, bone mineral density, and fractures in Slovak postmenopausal women.

Authors:  Iveta Boroňová; Jarmila Bernasovská; Soňa Mačeková; Eva Petrejčíková; Zlatica Tomková; Ján Kľoc; Janka Poráčová; Marta Mydlárová Blaščáková; Eva Litavcová
Journal:  J Appl Genet       Date:  2014-10-17       Impact factor: 3.240

4.  Association between osteoprotegerin gene polymorphism and bone mineral density in patients with adolescent idiopathic scoliosis.

Authors:  Il-Soo Eun; Weon Wook Park; Kuen Tak Suh; Jeung Il Kim; Jung Sub Lee
Journal:  Eur Spine J       Date:  2009-08-25       Impact factor: 3.134

5.  Association analyses of RANKL/RANK/OPG gene polymorphisms with femoral neck compression strength index variation in Caucasians.

Authors:  Shan-Shan Dong; Xiao-Gang Liu; Yuan Chen; Yan Guo; Liang Wang; Jian Zhao; Dong-Hai Xiong; Xiang-Hong Xu; Robert R Recker; Hong-Wen Deng
Journal:  Calcif Tissue Int       Date:  2009-05-21       Impact factor: 4.333

6.  Polymorphisms and haplotypes across the osteoprotegerin gene associated with bone mineral density and osteoporotic fractures.

Authors:  S Jurado; X Nogués; L Agueda; N Garcia-Giralt; R Urreizti; G Yoskovitz; L Pérez-Edo; G Saló; R Carreras; L Mellibovsky; S Balcells; D Grinberg; A Díez-Pérez
Journal:  Osteoporos Int       Date:  2009-05-13       Impact factor: 4.507

7.  Osteoprotegerin Lys3Asn polymorphism and the risk of fracture in older women.

Authors:  S P Moffett; J I Oakley; J A Cauley; L Y Lui; K E Ensrud; B C Taylor; T A Hillier; M C Hochberg; J Li; S Cayabyab; J M Lee; G Peltz; S R Cummings; J M Zmuda
Journal:  J Clin Endocrinol Metab       Date:  2008-03-04       Impact factor: 5.958

8.  Associations between OPG and RANKL polymorphisms, vertebral fractures, and abdominal aortic calcification in community-dwelling older subjects: the Sao Paulo Ageing & Health Study (SPAH).

Authors:  R M R Pereira; C P Figueiredo; C C Cha; V F Caparbo; R M Oliveira; A S Franco; P R Menezes; I de Castro; L F Onuchic
Journal:  Osteoporos Int       Date:  2016-06-16       Impact factor: 4.507

9.  TNFRSF11B computational development network construction and analysis between frontal cortex of HIV encephalitis (HIVE) and HIVE-control patients.

Authors:  Ju X Huang; L Wang; Ming H Jiang
Journal:  J Inflamm (Lond)       Date:  2010-09-30       Impact factor: 4.981

10.  Influence of polymorphisms in the RANKL/RANK/OPG signaling pathway on volumetric bone mineral density and bone geometry at the forearm in men.

Authors:  Delnaz Roshandel; Kate L Holliday; Stephen R Pye; Kate A Ward; Steven Boonen; Dirk Vanderschueren; Herman Borghs; Ilpo T Huhtaniemi; Judith E Adams; Gyorgy Bartfai; Felipe F Casanueva; Joseph D Finn; Gianni Forti; Aleksander Giwercman; Thang S Han; Krzysztof Kula; Michael E Lean; Neil Pendleton; Margus Punab; Alan J Silman; Frederick C Wu; Wendy Thomson; Terence W ONeill
Journal:  Calcif Tissue Int       Date:  2011-10-02       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.